AI isn’t close to curing cancer. Vivodyne says it knows what it will take; plus, TerraPower’s nuclear reactor has a secret weapon for powering AI data centers

Om avsnittet

A handful of AI-designed drugs have proceeded into human trials — one as far as Phase III, widespread human testing — but the reality is that the roadblocks aren’t necessarily ones that AI can solve today.

Also, TerraPower's nuclear power plant possesses a strategic advantage over competitors, especially when chasing after data center deals.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

Om avsnittet

Fler avsnitt

Photon held a funeral for mobile apps; plus, Kevin Mandia’s new ‘agent swarm’ security startup

World’s first enhanced geothermal power plant completed in just 23 months; plus, turning idle car inventory into rental revenue

Factory CEO just accused his VC board adviser of spying for Cognition

Ex-Tesla team raises $12.5M to put supply chains on autopilot; plus, EliseAI raises $350M, doubles valuation to $4B

AMD will acquire Fei-Fei Li’s World Labs for $8.2 billion; Physical AI chip developer SiMa AI hits $1.45B valuation

Ocean surveillance startup Quartermaster raises another $140M

Nexterity wants to automate the hard, dangerous part of pipefitting; plus, Feather is building the ‘Android of robotics’ for developers

Modal Motors is trying to cut China out of electric motors entirely; plus, PitPro’s first tire-changing robot goes live in Canada

a16z is challenging Silicon Valley’s love for drop-outs by launching a school; plus, AstroForge is putting AI in command of its next spacecraft

A small but growing number of founders are betting on bringing people together offline